HCA: New financial obligation · Other company developments

Item 8.01 below is incorporated by reference into this Item 2.03. Item 8.01. Other Events On July 29, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), increased the size of its commercial paper program under which the Issuer may issue unsecured commercial paper notes (the “Notes”) from time to time from a maximum aggregate face or principal amount of $4.0 billion outstanding at any time to a maximum aggregate face or principal amount of $8.0 billion outstanding at any time. The Notes are unconditionally guaranteed by the Parent Guarantor. The other terms and conditions of the commercial paper program remain as previously described in the Parent Guarantor’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 10, 2025. The Notes (and the related guarantee by the Parent Guarantor) have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or state securities laws and have not been and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The information contained in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any Notes. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. By: /s/ John M. Franck II John M. Franck II Vice President - Legal and Corporate Secretary Date: July 29, 2026